Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/09/2009EP2130544A2 Processes for obtaining lignan extracts and compositions containing the lignan extracts
12/09/2009EP2130541A2 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/09/2009EP2130540A1 Pharmaceutical compositions containing a crystalline form of posaconazole
12/09/2009EP2130539A1 Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia
12/09/2009EP2130538A1 Use of a cholinesterase inhibitor for the delaying the onset of Alzheimer's disease
12/09/2009EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009EP2130535A1 Application of isoflavones for the production of medicine
12/09/2009EP2130534A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450
12/09/2009EP2130533A1 Ataractic agent and functional food
12/09/2009EP2130532A1 Method for treating conditions associated with the accumulation of excess extracellular matrix
12/09/2009EP2130436A1 Method of controlling zoological and aquatic plant growth
12/09/2009EP2129677A1 Heterocyclic cyclopamine analogs and methods of use thereof
12/09/2009EP2129673A1 Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
12/09/2009EP2129672A1 Azaadamantane ester and carbamate derivatives and methods of use thereof
12/09/2009EP2129669A1 Pyridinone derivative for the treatment of premature ejaculation
12/09/2009EP2129668A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
12/09/2009EP2129666A2 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
12/09/2009EP2129665A1 Quinazolinone derivatives as aldh-2 inhibitors
12/09/2009EP2129663A2 Muscarinic receptor antagonists
12/09/2009EP2129662A2 C21-deoxy ansamycin derivatives as antitumor agents
12/09/2009EP2129661A1 Quinoline derivatives as crth2 receptor ligands
12/09/2009EP2129655A1 Prolinamide derivatives as modulators of voltage-gated sodium channels
12/09/2009EP2129654A1 Novel antagonists of the glucagon receptor
12/09/2009EP2129653A2 Novel p2y12 receptor antagonists
12/09/2009EP2129652A2 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
12/09/2009EP2129383A1 Treatment of anxiety disorders with minocycline
12/09/2009EP2129382A1 Compositions and methods for tranquilizing heart muscle
12/09/2009EP2129379A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors
12/09/2009EP2129378A1 Therapeutic compositions
12/09/2009EP2129377A1 Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine
12/09/2009EP2129374A1 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
12/09/2009EP2129373A1 Novel use of genistein
12/09/2009EP2129372A2 Anesthetic spray composition
12/09/2009EP2129370A1 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue
12/09/2009EP2129369A1 Treatment of adhd
12/09/2009EP2129366A2 Solid pharmaceutical and vaccine dose
12/09/2009EP2129364A2 Process for manufacturing ophthalmic oil-in-water emulsions
12/09/2009EP2129361A1 Topical composition comprising fluocinolone acetonide for use in depigmentation of the skin
12/09/2009EP2129280A2 Methods of diagnosing and alleviating gadolinium toxicity
12/09/2009EP2129224A1 5,6-dihydro-1h-pyridin-2-one compounds
12/09/2009EP2129219A1 Substituted fused-ring compounds for inflammation and immune-related uses
12/09/2009EP2129218A1 Compounds having a cyclic moiety and compositions for delivering active agents
12/09/2009EP2129216A1 Production of a viable, storable worm egg suspension
12/09/2009EP1991529B1 Substituted arylsulfonamides as antiviral agents
12/09/2009EP1981843B1 Vitamin d analog: nel, methods and uses thereof
12/09/2009EP1940848B1 Antimitotic rhizoxin derivatives of burkholderia rhizoxina, method for producing said derivatives and use thereof
12/09/2009EP1861113B1 Use of an onion extract for making a composition to control weight gain
12/09/2009EP1745040B1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
12/09/2009EP1735309B1 An improved process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides
12/09/2009EP1735296B1 Materials and methods for treating coagulation disorders
12/09/2009EP1720867B1 Process for the preparation of ziprasidone
12/09/2009EP1701942B1 Non-nucleotide reverse transcriptase inhibitors
12/09/2009EP1692140B1 Compositions useful as inhibitors of protein kinases
12/09/2009EP1678172B1 Azabicyclic compounds for relieving pain and treating central nervous system disorders
12/09/2009EP1673091B1 A combination comprising candesartan and rosuvastatin for the treatment of atherosclerosis
12/09/2009EP1648886B1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
12/09/2009EP1575578B1 Methods of treating injuries of the nervous system associated with hemorrhage
12/09/2009EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
12/09/2009EP1534286B1 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/09/2009EP1519939B1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/09/2009EP1518517B1 Drug-delivery endovascular stent
12/09/2009EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/09/2009EP1443933B1 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
12/09/2009EP1435964B1 Novel prodrugs of n-h bond-containing compounds and methods of making thereof
12/09/2009EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009EP1392642B1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/09/2009EP1300401B1 Thiazole derivatives for use as antiinflammatories
12/09/2009EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors
12/09/2009EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
12/09/2009EP1067109B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
12/09/2009EP0959905B1 Polysaccharide-peptide-conjugates
12/09/2009EP0910633B1 Hybrid polyketide synthase I gene
12/09/2009CN201356911Y Menthol ointment
12/09/2009CN101600726A Novel nucleoside analogs for treatment of viral infections
12/09/2009CN101600724A Nk1 receptor antagonist composition
12/09/2009CN101600721A A process for the preparation of polymorph form i of (s)-(+)-methyl-a-(2-chlorophenyl)-6,7-dyhidro-thieno-[3,2-c]pyridine-5(4h)-acetate hydrogen sulfate
12/09/2009CN101600720A Phosphoinositide 3-kinase inhibitor compounds and methods of use
12/09/2009CN101600719A Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol
12/09/2009CN101600718A Imidazo[1,2-B]pyridazine and pyrazolo[1,5-A]pyrimidine derivatives and their use as protein kinase inhibitors
12/09/2009CN101600717A 2- piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives
12/09/2009CN101600715A Compounds having both angiotensin ii receptor antagonism and ppary activating activities
12/09/2009CN101600714A Novel kinase inhibitors
12/09/2009CN101600712A Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity
12/09/2009CN101600710A Substituted dipyridyl-dihydropyrazolones and use thereof
12/09/2009CN101600708A Organic compounds
12/09/2009CN101600707A Urea compounds useful in the treatment of cancer
12/09/2009CN101600703A Dispiro tetraoxane compounds
12/09/2009CN101600700A Novel 2-aminooxazolines as TAAR1 ligands for CNS disorders
12/09/2009CN101600698A Quinazolinone and isoquinolinone acetamide derivatives
12/09/2009CN101600697A New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
12/09/2009CN101600696A Substituted arylpyrazoles
12/09/2009CN101600694A Composition for treatment of undifferentiated-type of gastric cancer
12/09/2009CN101600693A Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
12/09/2009CN101600692A Stable S-nitrosothiols, method of synthesis and use
12/09/2009CN101600686A Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
12/09/2009CN101600683A Therapeutic compounds
12/09/2009CN101600475A Small compounds that correct protein misfolding and uses thereof
12/09/2009CN101600474A 1,3-dihydroimidazoles for treating cardiovascular disorders
12/09/2009CN101600460A Ultrasound microbubble mediated genes delivery system
1 ... 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 ... 7860